Skip to main content
Fig. 1 | Trials

Fig. 1

From: Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)

Fig. 1

Empire HF hypotheses. SGLT2 sodium-glucose cotransporter 2, GFR glomerular filtration rate, eECV estimated extracellular volume, ePV estimated plasma volume, UACR urine albumin to creatinine ratio, NT-proBNP N-terminal pro-brain natriuretic peptide, MR-proADM mid-region pro-peptide of adrenomedullin, hs-cTNI high-sensitivity cardiac troponin I, LV left ventricular, KCCQ Kansas City cardiomyopathy questionnaire, EQ-5D-5 L EuroQol 5-dimension 5-level

Back to article page

Trials

ISSN: 1745-6215